Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin for Amblyopia (PATCH)
NCT07920081Phase 2Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Nov 2026
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
Phase 2, open-label trial of psilocybin in amblyopia (6 arms), sponsored by Johns Hopkins University. Primary endpoints: Change in Amblyopic Eye Visual Acuity and Change in Fellow Eye Visual Acuity. Started Nov 2026; status: recruiting.
02
Drugs
psilocybin
03
Conditions
amblyopia
Beyond the preview
Go deeper on NCT07920081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07920081.